Questions a plan sponsor actually asks.
What is Paclitaxel (Aibumin-Bound) used for?
Paclitaxel (Aibumin-Bound) is a Microtubule Inhibitor medication tracked in Medicare Part D.
Is there a generic for Paclitaxel (Aibumin-Bound)?
No. Paclitaxel (Aibumin-Bound) is brand-only with no generic equivalents currently in market.
How much does my plan pay for Paclitaxel (Aibumin-Bound)?
NADAC pricing data not currently available for this drug.
Is Paclitaxel (Aibumin-Bound) on the FDA shortage list?
No. Paclitaxel (Aibumin-Bound) is not currently on the FDA Drug Shortage Database.
5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.